Reviewed by the PeptideMind Team ยท Updated August 5, 2026

PNC-27 Peptide Dosage Guide, Benefits & Side Effects

PNC-27 peptide dosage guide covering research protocols, reconstitution, and benefits: selective HDM-2 cancer cell lysis with tumor eradication in preclinical studies, plus side effects and safety notes.

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

What is PNC-27?

PNC-27 is a lab-engineered peptide designed specifically to seek out and destroy cancer cells while leaving healthy cells alone. It works by targeting a protein found on the surface of cancer cells, causing those cells to rupture and die, while normal cells don't have the same target and stay unaffected. It's studied in early lab research across several cancer types, including breast, skin, blood, pancreatic, ovarian, and cervical cancers.

Longevity

pnc

Our top-rated vendor

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

Visit site
View all vendors

What Does PNC-27 Do?

It targets a protein (HDM-2) that shows up on the surface of cancer cells but not healthy ones, using that as a homing marker. Once attached, it punches holes straight through the cancer cell's outer membrane, causing it to break down and die.

Finds a cancer marker

Targets a protein found on cancer cells but not healthy ones.

Punches through the membrane

Creates pores straight through the cancer cell's outer membrane.

Cell breaks down

Causes the targeted cell to break down and die.

PNC-27 Targeted areas

Frequently Asked Questions About PNC-27

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

PNC-27 Reconstitution Guide

PNC-27 is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 2mg, 5mg, 10mg sizes.

5 mg lyophilized vial

PNC-27 is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 2mg, 5mg, 10mg sizes.

2 mL bacteriostatic water

Adding 2 mL of bac water to a 5 mg vial gives a workable concentration for syringe dosing. More water makes microdosing easier; less concentrates each draw.

Storage after mixing

Freeze the dry powder; it can handle room temperature for a few weeks. Once mixed with liquid, refrigerate and use within two weeks, or freeze it long-term with a protein stabilizer added, avoiding repeated freezing and thawing. After reconstitution, keep the vial refrigerated and use within 30 days.

Reconstitution steps

1

Remove caps & sanitize stoppers

2

Attach needle to syringe

3

Draw 2 mL bacteriostatic water

4

Insert needle into PNC-27 vial

5

Release water gently down the side

6

Swirl to dissolve โ€” don't shake

7

Check for full dissolution

8

Refrigerate PNC-27 โ€” good for 30 days

What Are the Benefits of PNC-27?

What research says it may help with, and how it works in the body.

cancer research

Has shown effectiveness at killing breast cancer cells in lab studies.

Kills a type of leukemia cell (called K-562) by attaching to a protein (HDM-2) found on the cell's surface, causing the cell to break down.

Selectively targets and attacks melanoma (skin cancer) cells.

In research, PNC-27 has been shown to selectively kill pancreatic cancer cells while largely sparing normal cells.

mechanism studies

Works best against cancer cells that have high amounts of a particular protein (HDM-2) on their outer surface.

Used by researchers as an example compound to study how to design treatments that target cancer cells while sparing healthy ones.

What Are the Side Effects of PNC-27?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Not approved for human use

Experimental research peptide only

Cancers without membrane HDM-2 may not respond

Stop Right Away If You Notice

Not applicable - not approved for human use

Milder Signs to Watch For

DiscolorationCloudy solutionParticulates visible
Was it helpful?Yes
No

Is PNC-27 FDA approved?

PNC-27 is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

PNC-27 has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

A smartphone screen displaying FDA status for a drug, indicating "FDA approved drug: No" and "Classification: Research use only." A banner notes "Research Only" with the disclaimer "not for human use," emphasizing its intended use for laboratory and analytical purposes.

PNC-27 Cycle Length: How Long Should It Last?

This breaks down how long a typical PNC-27 cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Week 0-0
Binding to membrane HDM-2 begins
Week 0-0
Pore formation and cancer cell necrosis
Week 0-0
Tumor reduction in animal models
Week 0-0
Human clinical trials not yet conducted

PNC-27 Research References

It is a preclinical compound

4Research references

PNC-27

PNC-27 is a preclinical compound

Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes

PNC-27 binds membrane-bound HDM-2, inducing pore formation and cancer cell necrosis while sparing normal cells.

n.d.

PNC-27 Induces Tumor Cell Necrosis of Leukemia Cells

PNC-27 induces necrosis of K-562 leukemia cells lacking p53 through p53-independent pathway.

n.d.

PNC-27, a Chimeric p53-Penetratin Peptide

PNC-27 binds HDM-2 in p53 peptide-like structure, induces selective membrane-pore formation leading to cancer cell lysis.

n.d.